What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Bumetanide New
PRAC signal recommendation
|
14/08/2024
Risko for toxic epidermal necrolysis and Stevens-Johnson syndrome. Further information and amendments to the product information can be found on the EMA website.
Safety warnings
|
Blood & Tissue
|
14/08/2024
The Federal Office for Safety in Health Care was informed of two confirmed autochthonous WNV cases in northern Burgenland.
Acetazolamide New
PRAC signal recommendation
|
14/08/2024
Pulmonary oedemas. Further information and amendments to the product information can be found on the EMA website.
Minoxidil (topical formulation) New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Clevidipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Nimodipine New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
Ceftazidime New
PSUR-outcome
|
14/08/2024
Further information and amendments to the product information can be found on the EMA website.
14/08/2024
Das Bundesamt für Sicherheit im Gesundheitswesen wurde über zwei bestätigte autochthone WNV-Fälle im Nordburgenland informiert.
Referenced at:
Buprenorphine/Naloxone New
PSUR-outcome
|
06/08/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Buprenorphine (all formulations except implants) New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.